CD19 and metabolic dysfunction-associated steatotic liver disease: We first compared the total number of CD19+CD20+ B cells in the blood of humans and mice with MASLD (Fig. S8A, B, respectively) and detected that the numbers of these cells were only moderately but not significantly elevated in both humans and mice with MASLD.